Decoding new DNA 'letters' to advance medicine and biotechnology

A research team led by the A*STAR Genome Institute of Singapore (A*STAR GIS) has developed a new method for reading DNA that contains non-standard bases, which was previously deemed too complex for conventional DNA sequencers. This innovative approach combines nanopore sequencing with artificial intelligence (AI) to decode these additional "letters" in DNA with high speed and accuracy. The findings of this research were published in Nature Communications. The advancements in DNA sequencing technology have significant implications for the detection and management of diseases, including leishmaniasis, a parasitic disease transmitted by sand flies. The ability to accurately and efficiently read DNA containing non-standard bases may enhance the understanding and tracking of leishmaniasis, which poses challenges for public health experts and veterinarians due to its complex transmission cycle. The new DNA test aims to improve diagnostic capabilities and management strategies for this disease. In addition to the developments related to leishmaniasis, the research also highlights a novel methylation analysis method called UMBS-seq, which addresses long-standing flaws in traditional bisulfite sequencing that damages DNA. This enzyme-based alternative offers a more consistent approach to analyzing DNA methylation, further contributing to advancements in genetic research. Overall, the work conducted by A*STAR GIS represents a significant step forward in the field of genetic research, with potential applications in various areas of medicine and biotechnology. The ability to decode non-standard DNA bases could lead to improved diagnostic tools and treatment strategies for a range of diseases, thereby enhancing public health outcomes.